CClinicalTrials.gg
CompletedNCT04828018Updated Apr 3, 2024

Care of the Ageing Veteran Population: Developing an Evidence Base for the Royal Hospital Chelsea Model of Care

An observational study in Quality of Life and Aging Well, sponsored by Northumbria University. Completed at 1 site in United Kingdom. Per ClinicalTrials.gov, last updated 2024-04-03.

Sponsored by Northumbria University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
61
Sex
All
01

Study summary

Royal Hospital Chelsea (RHC) has provided a sheltered housing environment alongside integrated health and social care and comradeship for British Army veterans since 1692, following a decree by King Charles II to aid the "relief of veterans broken by age and war" (RHC, 2018). Today approximately 300 In-Pensioners, known globally as 'Chelsea Pensioners' live at RHC. They also have access to an on-site infirmary providing nursing or personal care for up to 68 people (CQC, 2019).

RHC is in central London (UK) and comprises of several historical buildings, protected by the organisations Mission Statement to "...safeguard their historic home for the veterans of tomorrow". In-Pensioner's must have served in the British Army as a non-commissioned officer (or have served at least 12 years 'in the ranks' prior to becoming a commissioned officer), be aged 65 or over, be free of any financial obligations to dependents, and at the time of admission be able to live independently. Traditionally a male-only residence, RHC welcomed its first female Army veteran in 2009.

There is an absence of evidence to support the impact of care delivery and the Chelsea Pensioner experience, with the only evidence being RHC Annual and Care Quality Commission (CQC) reports which focus on strategic and operational matters rather than the impact of the wider social care or environment.

This lack of evidence presents a unique opportunity to evaluate RHC's current service provision, inform future direction and address the hiatus in evidence-based research to quantify the impact of its model of care.

Read the detailed description

The research will seek to address two main aims:

  1. To gain an understanding of the current Royal Hospital Chelsea (RHC) model of care by:

    1. Evidencing the influence the model of care has on In-Pensioner health outcomes
    2. Understanding the influence the model of care has on wider social care provision
    3. Reflecting on the contribution the environment has on the In-Pensioner experience, their health outcomes, and quality of life
  2. To inform future RHC care provision by:

    1. Mapping current services, future need and sustainability of the model
    2. Projecting findings to inform the growth of existing services for future generations of ageing veterans

The findings will inform RHC strategic direction as it continues to deliver care provision to current and future generations of veteran, identify the value of RHC interventions, and explore any development of service provision in the form of potential outreach care. Further, the findings will look to inform wider social care provision which may contribute to national health and social care policy.

The findings of the study may be applicable to the wider care provision within similar residential care establishments as they will seek to present service delivery findings from both a staff (care provider) and resident (care recipient) perspective and evidence best practice.

The findings may contribute to national health and social care policy (UK).

Key staff and Royal Hospital Chelsea 'In-Pensioner' residents will be interviewed for this study. New In-Pensioner residents will be invited to complete two Quality of Life Questionnaires (one on arrival and one six months later).

02

Conditions studied

  • Quality of Life
  • Aging Well
03

In context

Lead sponsor

Northumbria University is the lead sponsor of 156 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population comprises key staff employees of Royal Hospital Chelsea (n=19), residents of Royal Hospital Chelsea (known as In-Pensioners) (n=25) and new In-Pensioners (n=40)who are admitted to the institution over a 12 month period (to complete n=2 Quality of Life Questionnaires only)

Inclusion criteria

  • Participants identified as Key Staff, In-Pensioner residents and new In-Pensioners at Royal Hospital Chelsea will be eligible to be included in the study.

Exclusion criteria

Exclusion Criteria:

  • Anyone who is not employed by Royal Hospital Chelsea and identified as a Key Member of staff, or is not an In-Pensioner resident at Royal Hospital Chelsea will be excluded from the study.
  • Any potential participant who does not complete a consent form will be excluded from the study.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
61 participants (actual)
Patient registry
No

Groups and cohorts

  • Key Staff

    Key Staff will take part in one interview lasting up to 60 minutes

    Other: Coffee Morning · Other: Recruitment Leaflets · Other: Consent Form completion · Other: Participant Information Sheet · Other: Key Staff Interviews

  • In-Pensioners

    Royal Hospital Chelsea In-Pensioners will take part in one interview lasting up to 90 minutes and complete n=2 Quality of Life Questionnaires (ICECAP-A and WHOQOL-BREF) at the start of their qualitative interview.

    Other: Coffee Morning · Other: Recruitment Leaflets · Other: Consent Form completion · Other: Participant Information Sheet · Other: In-Pensioner Resident Interviews · Other: ICECAP-A Quality of Life Questionnaire · Other: WHOQOL-BREF Quality of Life Questionnaire

  • New In-Pensioner

    New In-Pensioners wil be asked to complete a total of n=4 Quality of Life Questionnaires (ICECAP-A and WHOQOL-BREF), n=2 on admission to Royal Hospital Chelsea and n=2 six months after admission.

    Other: New In-Pensioner Resident Information Pack · Other: ICECAP-A Quality of Life Questionnaire · Other: WHOQOL-BREF Quality of Life Questionnaire

Interventions

  • OtherCoffee Morning

    Coffee mornings (a maximum of n=2) will be held to raise awareness of the project and to promote participant recruitment. These will be held remotely via video conference if Covid-19 restrictions prevent in-person attendance by the researcher.

  • OtherRecruitment Leaflets

    Recruitment leaflets will be hand-delivered to all In-Pensioner residents at Royal Hospital Chelsea. Leaflets will be delivered internally by Royal Hospital Chelsea internal mail-room

  • OtherConsent Form completion

    All participants will be asked to complete Consent Forms before engaging in the study. The researcher will be available to answer any questions via phone calls if required.

  • OtherParticipant Information Sheet

    All participants will receive Information Sheets which they will read in their own rooms (or elsewhere for Key Staff). The researcher will be available to answer any questions via phone calls if required.

  • OtherNew In-Pensioner Resident Information Pack

    New In-Pensioner resident information packs will be distributed by a member of RHC staff as part of their 'arrivals' process and six months after residency at RHC. The researcher will be available to answer any questions via phone calls if required.

  • OtherKey Staff Interviews

    Key Staff interviews will take place with the Researcher in a private space at Royal Hospital Chelsea. If Covid-19 restrictions are in place, 'online' interviews will take place using a digital platform such as 'Skype', 'Teams' or 'Zoom'.

  • OtherIn-Pensioner Resident Interviews

    In-Pensioner resident interviews will take place with the Researcher in a private space at Royal Hospital Chelsea. If Covid-19 restrictions are in place, 'online' interviews will take place using a digital platform such as 'Skype', 'Teams' or 'Zoom'.

  • OtherICECAP-A Quality of Life Questionnaire

    New In-Pensioner residents and In-Pensioner residents taking part in the Qualitative Interviews will be asked to complete n=2 QoL questionnaires. New In-Pensioners will be asked to complete their QoL measures when the individual takes up residence at Royal Hospital Chelsea, the second six months later. In-Pensioner residents taking part in the interviews will be asked to complete the questionnaire at the start of the interview.

  • OtherWHOQOL-BREF Quality of Life Questionnaire

    New In-Pensioner residents and In-Pensioner residents taking part in the Qualitative Interviews will be asked to complete n=2 QoL questionnaires. New In-Pensioners will be asked to complete their QoL measures when the individual takes up residence at Royal Hospital Chelsea, the second six months later. In-Pensioner residents taking part in the interviews will be asked to complete the questionnaire at the start of the interview.

06

What researchers measure

Primary outcomes

  1. Key Staff Interviews

    Semi-structured 'in-person' interviews will take place with n=25 key staff at Royal Hospital Chelsea. Analysis of this data will be assessed using NVIVO software.

    Time frame: Interviews, lasting 60 minutes per interview, will take place over a 3-month period. Data analysis will take place over a 10-month period during years two and three of the study.

  2. In-Pensioner Interviews

    Semi-structured 'in-person' interviews will take place with n=25 Royal Hospital Chelsea In-Pensioner residents. Analysis of this data will be assessed using NVIVO software.

    Time frame: Interviews, lasting up to 90 minutes per interview, will take place over an 8-month period. Data analysis will take place over a 10-month period during years two and three of the study.

  3. Royal Hospital Chelsea Documentation Review

    Royal Hospital Chelsea documents including organisational policies, annual reports, healthcare governance reports and data from the Margaret Thatcher Infirmary will be reviewed. Data collected will be analysed using SPSS software.

    Time frame: Documentation review and data analysis will take place ahead of the writing-up phase of the study, approximately 15 months.

  4. ICECAP-A Quality of Life Questionnaire

    The ICECAP-A Quality of Life questionnaire will be completed by new In-Pensioner residents, and In-Pensioners selected for Qualitative Interview at Royal Hospital Chelsea. Data analysis will take place using SPSS software. ICECAP-A is the ICEpop CAPability measure for Adults Quality of Life measure and is scored using the Likert Scale framework. The questionnaire has a minimum value of 1 and a maximum value of 4, with the maximum value indicating a better outcome.

    Time frame: Questionnaires will be completed over a 12-month period during years two and three of the study. Data analysis will take place over a 10-month period during years two and three of the study.

  5. WHOQOL-BREF Quality of Life Questionnaire

    The WHOQOL-BREF Quality of Life questionnaire will be completed by new In-Pensioner residents, and In-Pensioners selected for Qualitative Interview at Royal Hospital Chelsea. Data analysis will take place using SPSS software. The WHOQOL-BREF is the World Health Organisation Quality of Life - Brief questionnaire which is a short-form version of the WHOQOL-100 Quality of Life measure and is scored using the Likert Scale framework. The questionnaire has a minimum value of 1 and a maximum value of 5, with the maximum value indicating a better outcome.

    Time frame: Questionnaires will be completed over a 12-month period during years two and three of the study. Data analysis will take place over a 10-month period during years two and three of the study.

07

Study locations

1 site
  • Royal Hospital Chelsea
    London, SW3 4SR, United Kingdom
08

References and documents

Individual participant data

Plan to share: Undecided — Currently in discussion

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04828018
Lead sponsor
Northumbria University
Collaborators
Royal Hospital Chelsea
Responsible party
Sponsor
First posted
Apr 1, 2021
Start date
May 11, 2021
Primary completion
Nov 7, 2022
Completion
Jan 24, 2024
Last update
Apr 3, 2024

Study contacts

Gemma Wilson-Menzfeld, PhD
principal investigator · Northumbria University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion